Pacific Biosciences of California (PACB) executive compensation, 2026 proxy

Christian O. Henry, President and Chief Executive Officer, was paid $4.3M in 2025, down 53% from $9.2M the year before. The CEO-to-median-employee pay ratio was 22:1, on median employee pay of $198,541.

Filed
April 23, 2026
Annual meeting
June 3, 2026
Pay year
2025
Named executives
3
CEO total pay
$4.3M-53% vs prior year
CEO to median employee
22:1median $198,541
CEO pay in equity
66%$2.8M in awards
Prior say-on-pay support
60%of votes cast
2025 Revenue
$160.0MFinancial highlight
Revio orders shipped
61Operational highlight
Vega orders shipped
140Operational highlight
Shareholders engaged
28%Of outstanding shares

How Henry was paid

$4.3M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary17%Stock awards27%Option awards39%Non-equity incentive17%

Named executive officers

ExecutiveTotal
Christian O. HenryPresident and Chief Executive Officer$4,309,846
Jim R. GibsonChief Financial Officer$3,493,189
Mark Van OeneChief Operating Officer$2,366,113

What changed and why

  • $4.3MChristian O. Henry received total compensation of $4,309,846 in 2025, down from $9,181,620 in 2024.
  • $160.0MRevenue for 2025 was recorded at $160.0 million alongside the sale of short-read assets for $48.1 million.
  • Stock options were reintroduced into the executive officer equity program for 2025.
  • 60%Say-on-pay support from shareholders dropped to approximately 60% at the 2025 annual meeting.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.